Literature DB >> 10202041

A fatal cytokine-induced systemic inflammatory response reveals a critical role for NK cells.

W E Carson1, H Yu, J Dierksheide, K Pfeffer, P Bouchard, R Clark, J Durbin, A S Baldwin, J Peschon, P R Johnson, G Ku, H Baumann, M A Caligiuri.   

Abstract

The mechanism of cytokine-induced shock remains poorly understood. The combination of IL-2 and IL-12 has synergistic antitumor activity in vivo, yet has been associated with significant toxicity. We examined the effects of IL-2 plus IL-12 in a murine model and found that the daily, simultaneous administration of IL-2 and IL-12 resulted in shock and 100% mortality within 4 to 12 days depending on the strain employed. Mice treated with IL-2 plus IL-12 exhibited NK cell apoptosis, pulmonary edema, degenerative lesions of the gastrointestinal tract, and elevated serum levels of proinflammatory cytokines and acute phase reactants. The actions of TNF-alpha, IFN-gamma, macrophage-inflammatory protein-1alpha, IL-1, IL-1-converting enzyme, Fas, perforin, inducible nitric oxide synthase, and STAT1 did not contribute to the observed toxicity, nor did B or T cells. However, toxicity and death from treatment with IL-2 plus IL-12 could be completely abrogated by elimination of NK cells. These results suggest that the fatal systemic inflammatory response induced by this cytokine treatment is critically dependent upon NK cells, but does not appear to be mediated by the known effector molecules of this cellular compartment. These data may provide insight into the pathogenesis of cytokine-induced shock in humans.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10202041

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

1.  Changes of inflammation-associated cytokine expressions during early phase of experimental endotoxic shock in macaques.

Authors:  Xiao-Hui Ji; Ke-Yi Sun; Yan-Hong Feng; Guo-Qing Yin
Journal:  World J Gastroenterol       Date:  2004-10-15       Impact factor: 5.742

2.  Comparison of the Superagonist Complex, ALT-803, to IL15 as Cancer Immunotherapeutics in Animal Models.

Authors:  Peter R Rhode; Jack O Egan; Wenxin Xu; Hao Hong; Gabriela M Webb; Xiaoyue Chen; Bai Liu; Xiaoyun Zhu; Jinghai Wen; Lijing You; Lin Kong; Ana C Edwards; Kaiping Han; Sixiang Shi; Sarah Alter; Jonah B Sacha; Emily K Jeng; Weibo Cai; Hing C Wong
Journal:  Cancer Immunol Res       Date:  2015-10-28       Impact factor: 11.151

3.  STAT4 is required for antibacterial defense but enhances mortality during polymicrobial sepsis.

Authors:  C J Godshall; A B Lentsch; J C Peyton; M J Scott; W G Cheadle
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

4.  Pre-clinical toxicity assessment of tumor-targeted interleukin-12 low-intensity electrogenetherapy.

Authors:  S D Reed; S Li
Journal:  Cancer Gene Ther       Date:  2011-01-14       Impact factor: 5.987

5.  Plasma interleukin-6 concentration for the diagnosis of sepsis in critically ill adults.

Authors:  Daniel Molano Franco; Ingrid Arevalo-Rodriguez; Marta Roqué I Figuls; Nadia G Montero Oleas; Xavier Nuvials; Javier Zamora
Journal:  Cochrane Database Syst Rev       Date:  2019-04-30

Review 6.  Natural killer (NK) cells in antibacterial innate immunity: angels or devils?

Authors:  Fernando Souza-Fonseca-Guimaraes; Minou Adib-Conquy; Jean-Marc Cavaillon
Journal:  Mol Med       Date:  2012-03-30       Impact factor: 6.354

7.  Conditional interleukin-12 gene therapy promotes safe and effective antitumor immunity.

Authors:  H Komita; X Zhao; A K Katakam; P Kumar; M Kawabe; H Okada; J M Braughler; W J Storkus
Journal:  Cancer Gene Ther       Date:  2009-05-15       Impact factor: 5.987

8.  The antitumor effects of IFN-alpha are abrogated in a STAT1-deficient mouse.

Authors:  Gregory B Lesinski; Mirela Anghelina; Jason Zimmerer; Timothy Bakalakos; Brian Badgwell; Robin Parihar; Yan Hu; Brian Becknell; Gerard Abood; Abhik Ray Chaudhury; Cynthia Magro; Joan Durbin; William E Carson
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

9.  Coexpression of IL-18 strongly attenuates IL-12-induced systemic toxicity through a rapid induction of IL-10 without affecting its antitumor capacity.

Authors:  Maria Cecilia Rodriguez-Galan; Della Reynolds; Silvia G Correa; Pablo Iribarren; Morihiro Watanabe; Howard A Young
Journal:  J Immunol       Date:  2009-06-17       Impact factor: 5.422

10.  Toll-like receptor 2- and 6-mediated stimulation by macrophage-activating lipopeptide 2 induces lipopolysaccharide (LPS) cross tolerance in mice, which results in protection from tumor necrosis factor alpha but in only partial protection from lethal LPS doses.

Authors:  Ursula Deiters; Marina Gumenscheimer; Chris Galanos; Peter F Mühlradt
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.